Sign in

CIK 0002012593 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Rapport Therapeutics, Inc.

Sign in to watch
Ticker
RAPP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
880724208
Phone
857-321-8020
Business address
99 HIGH STREET, SUITE 2100, BOSTON, MA, 02110
Former names
Rapport Therapeutics, Inc.
Open-market buys, last 90 days
$22,023,904
in 7 filings
Open-market sales, last 90 days
$4,490,340
in 8 filings, $4.5M under 10b5-1 plans

Net +$17,533,565. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. HEALY JAMES +$20.4M Director 1 filing
  2. Yeleswaram Krishnaswamy −$2.6M Chief Development Officer sold 21% of stake
  3. Ceesay Abraham −$1.6M Chief Executive Officer sold 7% of stake
  4. PAUL STEVEN M +$974K Director 1 filing
  5. Gault Cheryl −$332K Chief Operating Officer sold 7% of stake
Date Insider Transaction Shares Price Value Owned after
2026-10-30 Third Rock Ventures V, L.P. Director Grant or award +238,095 $21.00 $5.0M 6,518,620
2026-10-30 Third Rock Ventures V, L.P. Director Grant or award +1,190,476 $21.00 $25.0M 2,159,694
2026-10-28 HEALY JAMES Director Purchase +952,380 $21.00 $20.0M 2,815,707
2026-10-28 HEALY JAMES Director Purchase +6,395 $21.00 $134K 17,990
2026-10-28 HEALY JAMES Director Purchase +3,772 $21.00 $79K 14,924
2026-10-28 HEALY JAMES Director Purchase +6,933 $21.00 $146K 25,267
2026-10-23 Sanchez Ramiro Director Purchase +3,600 $27.35 $98K 3,600
2026-10-22 Silva Paul M Director Purchase +3,680 $27.08 $100K 3,680
2026-10-22 Young Wendy B. Director Purchase +3,789 $26.39 $100K 13,289
2026-10-22 PAUL STEVEN M Director Purchase +35,714 $27.28 $974K 77,380
2026-10-22 MARAGANORE JOHN Director Purchase +8,239 $26.38 $217K 8,239
2026-10-22 MARAGANORE JOHN Director Purchase +1,172 $26.92 $32K 9,411
2026-10-21 Ceesay Abraham Chief Executive Officer Sale 10b5-1 −2,210 $29.16 $64K 450,035
2026-10-21 Ignelzi Troy A. Chief Financial Officer Purchase +5,500 $26.10 $144K 15,500
2026-10-07 Ceesay Abraham Chief Executive Officer Sale 10b5-1 −1,147 $30.66 $35K 452,245
2026-10-06 Ceesay Abraham Chief Executive Officer Sale 10b5-1 −3,375 $32.03 $108K 453,392
2026-09-30 Gault Cheryl Chief Operating Officer Sale 10b5-1 −7,925 $33.04 $262K 141,989
2026-09-30 Gault Cheryl Chief Operating Officer Sale 10b5-1 −2,075 $33.76 $70K 139,914
2026-09-23 Ceesay Abraham Chief Executive Officer Sale 10b5-1 −1,952 $39.05 $76K 457,025
2026-09-23 Ceesay Abraham Chief Executive Officer Sale 10b5-1 −215 $39.86 $9K 456,810

Page 1 of 10 · 186 trades